Champion Free Press
Support Asian Financial Daily with $15 each month!
Explore by Topics
Subscribe
Search
Have an existing account? Sign In
biopharma
China’s biopharma market strikes $30b in oncology licensing offers
In 2024, antibody-drug conjugates controlled the licensing project. China’s biopharmaceutical market has actually seen a sharp surge in oncology medication…
India, China, Brazil, and Japan are swiftly scaling their biopharma capacities.
India, China, Brazil and Japan are swiftly broadening their biopharmaceutical capacities.
China’s biopharma market strikes $30b in oncology licensing offers
In 2024, antibody-drug conjugates controlled the licensing project. China’s biopharmaceutical market has actually seen a sharp surge in oncology medication…
The Daily Newsletter
